Miguel Abboud to Methotrexate
This is a "connection" page, showing publications Miguel Abboud has written about Methotrexate.
Connection Strength
1.113
-
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon. J Glob Oncol. 2019 04; 5:1-8.
Score: 0.606
-
Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Curr Res Transl Med. 2017 09; 65(3):115-119.
Score: 0.137
-
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2014 Aug; 24(8):387-96.
Score: 0.110
-
Predictors of bone loss in childhood hematologic malignancies: a prospective study. Osteoporos Int. 2012 Feb; 23(2):665-74.
Score: 0.087
-
First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate. Pediatr Blood Cancer. 2009 Feb; 52(2):308.
Score: 0.075
-
Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience. J Pediatr Hematol Oncol. 2004 Nov; 26(11):749-53.
Score: 0.056
-
Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon. J Pediatr Hematol Oncol. 2020 08; 42(6):e428-e433.
Score: 0.042